Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Research letter: The impact of elexacaftor/tezacaftor/ivacaftor on adherence to nebulized maintenance therapies in people with cystic fibrosis.
J Cyst Fibros. 2022 Nov;21(6):1080-1081. doi: 10.1016/j.jcf.2022.05.005. Epub 2022 May 16.
J Cyst Fibros. 2022.
PMID: 35585011
No abstract available.
Correction: Dagenais et al. Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review. J. Clin. Med. 2021, 10, 23.
Dagenais RVE, Su VC, Quon BS.
Dagenais RVE, et al.
J Clin Med. 2022 Jan 10;11(2):318. doi: 10.3390/jcm11020318.
J Clin Med. 2022.
PMID: 35054167
Free PMC article.
Item in Clipboard
Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review.
Dagenais RVE, Su VCH, Quon BS.
Dagenais RVE, et al.
J Clin Med. 2020 Dec 23;10(1):23. doi: 10.3390/jcm10010023.
J Clin Med. 2020.
PMID: 33374882
Free PMC article.
Review.
Item in Clipboard
Cite
Cite